Status:
UNKNOWN
Physiological Changes of the Mitral Annulus After Annuloplasty in Barlow Disease
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Barlow Disease (BD)
Mitral Insufficiency
Eligibility:
All Genders
18+ years
Brief Summary
Barlow disease (BD) is a common cause of mitral insufficiency. In 2012 the University Hospital of Basel started to perform a simplified mitral valve repair technique in BD just by implanting an annulo...
Eligibility Criteria
Inclusion
- identified Barlow disease suffering from significant mitral insufficiency with indication to surgery
Exclusion
- Active endocarditis or any other etiology of mitral insufficiency else than Barlow disease
- Inability to perform a cardiac MRI (e.g., metallic implants, claustrophobia)
- Pregnancy
- Inability to give consent
Key Trial Info
Start Date :
September 21 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04418960
Start Date
September 21 2018
End Date
April 1 2022
Last Update
August 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiac Surgery, University Hospital Basel
Basel, Switzerland, 4031